baber/WOPTO huggingface dataset:
Patent NZ-275066-A (NZ)
Title: Method of creating a localised antimicrobial effect achieved by sustained release of atoms, ions, molecules or clusters of at least one (heavy) metal into an alcohol or water based electrolyte
Inventor: BURRELL ROBERT EDWARD
IPC: A01N59/26
Filed: 1994-11-01
Abstract: Anti-microbial coatings and powders and method of forming same on medical devices are provides. The coatings are preferably formed by depositing an anti-microbial biocompatible metal by vapour deposition techniques to produce atomic disorder in the coating such that a sustained release of metal ions sufficient to produce an anti-microbial effect is achieved. Preferred deposition conditions to achieve atomic disorder include a lower than normal substrate temperature, and one or more of a higher than normal working gas pressure and a lower than normal angle of incidence of coating flux. Anti-microbial powders formed by vapour deposition or altered by mechanical working to produce atomic disorder are also provided. The anti-microbial effect of the coatings or powders may be further activated or enhanced by irradiating with a low linear energy transfer form of radiation such as gamma radiation. Novel anti-microbial silver materials are defined, characterized by having a positive rest potential, a Trec/Tm less than 0.33, and a grain size less than 200 nm. Anti-microbial fine grain or nanocrystalline materials are provided, together with methods of preparation, wherein the anti-microbial metal if deposited in a matrix with atoms or molecules of a different material such as other biocompatible metals (ex. Ta), trapped or absorbed oxygen, or compounds of anti-microbial metals or biocompatible metals (ex. Ag0 or TaO). The invention also extends to a method of producing an anti-microbial effect with silver materials that form complex silver ions other than Ag<+>, Ag<2+> and Ag<3+>.
Patent NZ-330443-A (NZ)
Title: 4,7-dialkoxy-n-acetylneuraminic acid derivatives and the detection of influenza virus
Inventor: LIAV AVRAHAM
IPC: G01N33/569
Filed: 1997-09-05
Abstract: Chromogenic and fluorogenic 4,7-dialkoxy-N-acetylneuraminic acid substrates of the general formula  l groups containing 1 to 4 carbon atoms and R3 is a chromogenic or fluorogenic group. These substrates can be used to detect influenza types A and B in clinical samples or specimens. More particularly, these 4,7-dialkoxy-N-acetylneuraminic acid substrates can be used to distinguish between various viruses having neuraminidase reactivity. Thus, influenza type A and B viruses can be distinguished from parainfluenza type 1, 2, 3, and 4, and mumps using the 4,7-dialkoxy-N-acetylneuraminic acid derivatives of this invention. Diagnostic methods employing these substrates are provided to identify influenza type A and B viruses in clinical specimens and to distinguish from other viruses having neuraminidase reactivity.
Patent NZ-333100-A (NZ)
Title: Plant retinoblastoma-associated proteins and their use in modulating the cell cycle of a plant
Inventor: GUTIERREZ-ARMENTA CRISANTO
IPC: C12N15/87
Filed: 1997-06-12
Abstract: The specification describes the isolation and characterization of a plant cell DNA sequence encoding for a retinoblastoma protein. The finding is based on the structural and functional properties of the plant retinoblastoma protein as possible regulator of the cellular cycle, of the cellular growth and of the plant cellular differentiation.  Specifically, the specification describes a method for controlling the transition of a plant cell from the G1 phase to the S phase of the cell cycle and is characterised in that it comprises increasing or decreasing the level and/or activity of retinblastoma protein in that plant cell.  The method comprises incorporating a recombinant nucleic acid into the cell which encodes a protein depicted by SEQ ID NO:2.
Patent NZ-333308-A (NZ)
Title: Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
Inventor: LATTMANN RENE
IPC: A61P39/04
Filed: 1997-06-24
Abstract: These 3,5-Diphenyl-1,2,4-triazoles are of the formula (I), where R1 and R5 each are H, halo, OH, alkyl, haloalkyl, alkoxy, haloalkoxy, carboxyl, carbamoyl, or nitrile, R2 and R4 each are H optionally substituted alkanoyl or aroyl, R3 is H, halo, OH, alkyl, haloalkyl, alkoxy, haloalkoxy, carboxyl, carbamoyl, or nitrile and R6 and R7 each are H, akyl, hydroxyalkyl, m alkoxyalkyl, aminoalkyl, or together with the N atom form an azaalicyclic ring.  The compounds have useful pharmaceutical properties and are particularly active as iron chelators.  They can be used for the treatment of an iron overload in the body of warm-blooded animals.
Patent NZ-333404-A (NZ)
Title: Automatic swimming pool cleaning system using an apparatus powered from the pressure side of a pump
Inventor: HENKIN MELVYN L
IPC: E04H4/16
Filed: 1997-05-06
Abstract: Disclosed is an automatic swimming pool cleaning method and apparatus for cleaning a water pool (1) contained in an open vessel (2) defined by a containment wall (3) having a bottom (4) and side (5) portions utilizing a unitary structure or body (6) configured for immersion in a pool (1) for selective operation proximate the water surface (7) in a surface cleaning mode or proximate to the interior wall surface portions (8) in a wall surface cleaning mode.  The cleaning apparatus is configured to be driven by a positive pressure source and comprises a level control subsystem for producing a vertical force and a propulsion control subsystem.
Patent NZ-333604-A (NZ)
Title: Piston-cylinder device for dispensing medicinal fluids
Inventor: VON SCHUCKMANN ALFRED
IPC: B65D83/76
Filed: 1997-05-28
Abstract: The specification describes a dispenser (G) for fluids (1), especially medicated fluids, from a mouthpiece aperture (2) connected to a fluid supply by the manual operation of a piston-cylinder device (4).  The manual control is released only after an overload threshold (ü) has been exceeded. The dispenser has a user-friendly construction and provides the supply of a powerful spray of fluid by means of a lower spring return force related to the overload threshold in the piston-cylinder device (4) in the form of a pump (P).
Patent NZ-334810-A (NZ)
Title: Internal mattress wall structures which interlock with mattress innerspring assemblies
Inventor: LANGER PAUL J
IPC: A47C27/06
Filed: 1997-09-30
Abstract: The specification is best illustrated by reference to FIG. 1wherein a cross-section of a mattress, indicated generally at 1,is taken across the width of the mattress so that the view is along the length of the mattress. The following describes a rectilinear mattress having orthogonal side and end walls, regardless of the lengths of the walls as may vary among different conventional mattress from twin to king. The specification pertains to mattress of all sizes.  The internal construction of the mattress includes an innerspring assembly, indicated generally at 10, including a plurality of spring coils 11 (referred to herein simply as "coils"), each having a series of intermediate helical convolutions 12 and top and bottom terminal convolutions, 13 and 14 respectively, each of the convolutions having a common generally vertically oriented axis. The coils 11 may be arranged in the innerspring assembly in any manner, but are most commonly arranged in rows to fill substantially the entire area within the generally rectilinear perimeter of a mattress, as described for example in U.S. Pat. No. 4,092,749, incorporated herein by reference, and shown in FIG. 8. The terminal convolutions 13 and 14 of each of the coils are commonly connected by cross-helical lacing wires 15 which are laced about the tangential terminal convolutions of the coil in adjacent rows, across the width of the innerspring assembly 10.  An end cross-helical wire is also installed along the terminal convolutions of the coils in the end rows of the innerspring assembly. However, because there may be no borderwire in the innerspring assembly with which the wall structures of the invention are engaged, there is no side helical wire about the terminal convolutions along the side of the innerspring assembly. Although described in this regard, it is understood that the mattress may embrace an innerspring assembly which is entirely conventional, having upper and lower border wires, and a helical lacing wire about the border wires and the perimetrical coils.
Patent NZ-335922-A (NZ)
Title: Use of leukotriene antagonists for treating squamous cell carcinoma (cancer)
Inventor: FLEISCH JEROME H
IPC: A61P25/28
Filed: 1997-12-02
Abstract: Disclosed is the use of the above compound, having activity as a leukotriene B4 antagonist, for the treatment or inhibition of oral squamous cell carcinoma. Treatment involves administering to a mammal in need thereof an effective amount of a compound of the formula I wherein: R1 is C1-C5 alkyl, C2-C5 alkenyl, C2-C5 alkynyl, C1-C4 alkoxy, (C1-C4 alkyl)thio, halo, or R2-substituted phenyl; R2 and R3 are each independently hydrogen, halo, hydroxy, C1-C4 alkyl, C1-C4 alkoxy, (C1-C4 alkyl)-S(O)q-, trifluoromethyl, or di-(C1-C3alkyl)amino; X is -O-, -S-, -C(=O), or -CH2-; Y is -O- or -CH2-, or when taken together, -X-Y- is -CH=CH- or -C=C-; Z is a straight or branched chain C1-C10 alkylidenyl; A is a bond, -0-, -S-, -CH=CH-, or -CRaRb-, where Ra and Rb are each independently hydrogen, C1-C5 alkyl, or R7-substituted phenyl, or when taken together with the carbon atom to which they are attached, form a C4-C8 cycloalkyl ring; R4 is R6, or figure Ia, Ib, Ic, Id, Ie or If' where, R6 is independently -COOH, 5-tetrazolyl, -CON(R9)2, or -CONHSO2Rl0; R7 is hydrogen, Cl-C4 alkyl, C2-Cs alkenyl, C2-C5 alkynyl, benzyl, methoxy, -W-R6, -T-G-R6, (C1-C4 alkyl)-T-(C1-C4 alkylidenyl)-O-, or hydroxy; R8 is hydrogen or halo; R9 is independently hydrogen, phenyl, or C1-C4 alkyl, or when taken together with the nitrogen atom form a morpholino, piperidino, piperazino, or pyrrolidino group; R10 is C1-C4 alkyl or phenyl; R11 is R2, -W-R6, or -T-G-R6; W is a bond or straight or branched chain divalent hydrocarbyl radical of one to eight carbon atoms; G is a straight or branched chain divalent hydrocarbyl radical of one to eight carbon atoms; T is a bond, -CH2-, -O-, -NH-, -NHCO-, -C(=O)-, or -S(O)q"-; K is -C(=O)- or -CH(OH)-; q is independently 0, 1, or 2; p is 0 or 1; t is 0 or 1; provided when X is -O- or -S-, Y is not -O-; provided when A is -O- or -S-, R4 is not R6; provided when A is -O- or -S- and Z is a bond, Y is not -0-; provided W is not a bond when p is 0;
Patent NZ-500647-A (NZ)
Title: Connecting optical fibres with pivoted push fitted housing members
Inventor: HOUGH STEPHEN JOHN
IPC: G02B6/24
Filed: 1998-04-29
Abstract: An assembly (10) is disclosed for connecting optical fibres comprising a plurality of housings (12) for housing optical fibre connections. Each housing is pivotally mounted with respect to an associated rigid routing member (14) which has passages for routing fibres to the housing via respective flexible conduit means which extend between the routing member and the housing. Adjacent routing members (14) are push-fitted together such that the housings (12) are in an aligned bank when in stowed positions. Each housing (12) is pivotable from its stowed position out of alignment with the other housings for access.
Patent NZ-503388-A (NZ)
Title: Apparatus for performing photometric assays using capillaries with photonic isolation from a neighboring capillary
Inventor: COMLEY JOHN CHARLES WILLIAM
IPC: G01N35/00
Filed: 1998-09-15
Abstract: An apparatus for the performance of photometric assays comprising: 1. A housing; 2. A plurality of translucent capillaries each being sealed at one end; 3. Means to provide each capillary with photonic isolation from a neighbouring capillary; and 4. Optical instrumentation and circuitry adapted to read an optical response or event in each capillary.
Patent NZ-504824-A (NZ)
Title: Composition containing an iron compound, an aluminium silicate and a calcium source useful for the removal of the phosphate ion content of waters
Inventor: ILLES GABORNE
IPC: C02F1/52
Filed: 1998-11-06
Abstract: A composition for removing the phosphate ion content of water comprises: a) 0.1 to 99.9 parts by mass of an iron compound selected from solid hydrous Fe(II) and Fe(III) salts b) 99.9 to 0.1 parts by mass of a porous aluminum silicate containing exchangeable ions and c) 0.1 to 10 moles of a calcium ion source of calcium carbonate with either calcium oxide or calcium hydroxide or both per mole of the iron compound. The components of the composition are dry grounded together.
Patent NZ-507902-A (NZ)
Title: Novel hepatitis vaccine composition
Inventor: ARTOIS CLAUDE
IPC: A61K39/295
Filed: 1999-04-27
Abstract: An aqueous vaccine composition comprising hepatitis B surface antigen, an inactivated hepatitis A virus and formol.  The composition also comprises 0.015-0.1mg aluminium phosphate per mg hepatitis B surface antigen and 0.05-0.1mg aluminium hydroxide per ml.
Patent NZ-512820-A (NZ)
Title: (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione useful for treating sexual disturbances
Inventor: MEGLASSON MARTIN DURHAM
IPC: A61K31/535
Filed: 1999-12-20
Abstract: (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2 (1H)-thione of formula (A) and its salts and a process of preparation thereof, wherein R1, R2, R3, A, B, D, n and X are as described in the disclosure.  These compounds are suitable for treating sexual disturbance such as hypoactive sexual desire disorder, female sexual arousal disorder, male erectile disorder, female orgasmic disorder, and male orgasmic disorder.
Patent NZ-515977-A (NZ)
Title: Gypsum compositions and related methods
Inventor: YU QIANG
IPC: C04B111/40
Filed: 2001-04-20
Abstract: A set gypsum composition prepared by a method comprising: (a) preparing a mixture from calcined gypsum, water and an enhancing material selected from the group consisting of a trimetaphosphate compound, an ammonium polyphosphate having 500-3000 repeating phosphate units, a polycarboxylic compound, a surfactant, and combinations thereof, wherein the weight ratio of water to calcined gypsum present in the mixture is at least 3:1, and (b) maintaining the mixture under conditions sufficient for the calcined gypsum to form an interlocking matrix of set gypsum.
Patent NZ-516990-A (NZ)
Title: Private telephone management system including multiple private line outputs and account management means
Inventor: SIMPSON AL
IPC: H04M3/42
Filed: 2002-02-01
Abstract: An apparatus for providing added functionality to a private telephone system, said private telephone system having inputs for multiple trunk lines and having multiple private line outputs, said apparatus comprising: a processing unit for monitoring one of said multiple private line outputs and operable to perform said added functionality: a talk battery; and a switch having an input for a single telephone, and an output selectable between one of said multiple private line outputs and said talk battery, said switch being controlled by said processing unit in accordance with said added functionality; said processing unit also having means for managing user accounts.
Patent NZ-517632-A (NZ)
Title: Formulations for parenteral use of estramustine phosphate and albumin
Inventor: MUGGETTI LORENA
IPC: A61K47/42
Filed: 2000-08-03
Abstract: A pharmaceutical formulation for use in treating cancer which comprises a parenterally acceptable carrier or diluent and estramustine phosphate in admixture with human albumin, wherein the weight ratio of estramustine phosphate to human albumin is from about 1:5 to about 1:0.3, respectively; and the use of said formulation in minimizing the side affects associated with intravenous administration of estramustine.
Patent NZ-517713-A (NZ)
Title: Enhanced viewing experience of a display through localised dynamic control of background lighting level
Inventor: EVANICKY DANIEL E
IPC: G02B27/22
Filed: 2002-06-25
Abstract: A method of controlling brightness, colour, hue, colour temperature, gamma response or contrast of at least one image for display on a multi layer display device comprises: i) receiving the at least one image(s) to be displayed; ii) detecting the brightness, colour, hue, colour temperature, gamma response or contrast of the image(s) to be displayed; iii) determining the transmissivity of each layer of the multi layer display device in the localized area of the image(s) to achieve the brightness, colour, hue, colour temperature, gamma response and/or contrast detected or received; iv) communicating the determined transmissivity of each layer of the multi layer display device in the localized area of the (images) to a display device or storage device. A method of controlling brightness, colour, hue, colour temperature, gamma response or contrast of at least one image for display on a multi layer display device comprises: i) receiving the at least one image(s) to be displayed; ii) detecting the brightness, colour, hue, colour temperature, gamma response or contrast of the image(s) to be displayed; iii) determining the transmissivity of each of the non-display layers of the multi layer display device in the localized area of the image(s) to achieve the brightness, colour, hue, colour temperature, gamma response and/or contrast detected or received and iv) communicating the determined transmissivity of the non-display layers of the multi layer display device in the localized area of the (images) to a display device or storage device.
Patent NZ-518190-A (NZ)
Title: Rapid oxygen absorption by using activators
Inventor: EVANS SUSAN P
IPC: B01J20/22
Filed: 2000-09-27
Abstract: A method of removing oxygen from a closed package by absorbing the oxygen with an iron-based absorbing composition contained in a packet and activated by introduction of an activator into the packet, wherein a liquid alcohol is included in the activator.
Patent NZ-525545-A (NZ)
Title: Improvements in or relating to tube couplings
Inventor: GUEST JOHN DEREK
IPC: F16L37/092
Filed: 2003-04-29
Abstract: A tube coupling has a coupling body (12) with a throughway (13) open at one end to receive an end portion of a tube (not shown). A seal (50) encircles the throughway to seal with the periphery and end of the tube and a cap (20) is mounted on the body having a tube locking device (23) rotatably mounted in the cap to engage and hold the tube in the cap. The cap and body have interengaging means (24, 25, 26, 27) which guide the cap on the body in an axial direction along the body with rotation of the cap from a first position in which a tube can be inserted through the cap and into the seal in the throughway and retained by the locking device and a second position advanced along the coupling body from said one end in which the tube end is held positively in engagement with the seal in the throughway. The locking device (23) engages via a ring with the coupling body to resist rotation of the locking device with respect to the body whereby rotation of the cap between said the first and second positions does not cause the tube to rotate.
Patent NZ-526290-A (NZ)
Title: Float valve
Inventor: ORETTI JOHN EARNEST
IPC: A01G27/00
Filed: 2001-11-27
Abstract: The float valve (11) controls water level e.g. in an associated plant pot. A housing (21) has a water inlet (25) with an inlet port (26), a float (31) able to rise and fall with the level of the water in the housing (21), a valve operating mechanism (60) able to open and close the port (26), and an actuator means (40) to operate the valve operating mechanism when the float (31) rises and falls to predetermined levels. For opening and closing the inlet port (26), there is a valve operating mechanism comprising a valve operator (60) having a valve member (67) and a lever (61) mounted for pivoting movement about generally central pivot point (65). Actuator means (40) is coupled to the float (31) and switches between a standby condition an active condition respectively to the closed and open positions of the valve operating mechanism (60). The actuator means (40) comprises an over-centre mechanism having an actuator (71) which is operatively associated with the valve operator (60), a float follower (41) movable in response to rising and falling of the float (31), and a spring mechanism (58) acting between force points on the float follower (41) and the actuator (71).
Patent NZ-529694-A (NZ)
Title: Solid orally-dispersible pharmaceutical formulation
Inventor: SERPELLONI MICHEL
IPC: A61K47/26
Filed: 2002-12-19
Abstract: Disclosed is an orodispersible solid pharmaceutical form, characterized by granules consisting of lactose and starch which have been codried; and at least one active substance, wherein the solid form disintegrates in the mouth in less than 3 minutes. The granules may represent between 20 and 99% of the solid form and the lactose:starch ratio maybe between 90:10 and 25:75.
Patent NZ-536142-A (NZ)
Title: Mechanical locking system for floorboards
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2003-03-31
Abstract: Floorboards (1, 1') are shown, which are provided with a mechanical locking system consisting of a separately machined locking strip (6) which is mechanically joined with the floorboard (1), the locking strip (6) being designed for mechanical fixing to the floorboard (1) by means of a joint, which is operable by snapping-in and/or inward angling, and the locking strip (6) being designed to connect the floorboard (1) with the essentially identical floorboard (1') by at least inward angling. Moreover, a locking strip, a strip blank, a set of parts for making a floorboard and methods for manufacturing a floorboard and a locking strip, respectively, are shown.
Patent NZ-542246-A (NZ)
Title: Optimized expression of HPV 31 L1 yeast
Inventor: JANSEN KATHRIN U
IPC: A61J1/03
Filed: 2004-03-19
Abstract: Disclosed is a nucleic acid molecule comprising a sequence of nucleotides that encodes an HPV31 L1 protein as set forth in SEQ ID NO:4, the nucleic acid sequence being codon-optimized for high level expression in a yeast cell.
Patent NZ-546887-A (NZ)
Title: Combinations useful for the treatment of neuronal disorders
Inventor: SCHULZ INGO
IPC: A61K31/00
Filed: 2004-10-29
Abstract: Disclosed is a combination, comprising at least one QC-inhibitor and at least one beta secretase inhibitor or at least one gamma secretase inhibitor. Also disclosed is the use of the above composition for the preparation of a medicament for the treatment of neuronal diseases in a mammal such as Alzheimer's diseases or Down syndrome.
Patent NZ-546992-A (NZ)
Title: Transdermal drug delivery device
Inventor: KANIOS DAVID P
IPC: A61K9/70
Filed: 2004-10-28
Abstract: A transdermal drug delivery composition is disclosed, wherein said composition comprises a a backing layer; at least one adhesive coating layer, a first surface of said at least one adhesive coating layer being affixed to one surface of said backing layer; at least one carrier composition layer, a first surface of said at least one carrier composition layer being affixed to a second surface of said at least one adhesive coating layer; and a removeable release liner affixed to a second surface of said at least one carrier composition layer, wherein said at least one carrier composition layer includes a therapeutically effective amount of one or more drugs incorporated into the at least one carrier composition layer. The transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.